COVID-19-related encephalopathy responsive to high-dose glucocorticoids

Neurology. 2020 Sep 22;95(12):543-546. doi: 10.1212/WNL.0000000000010354. Epub 2020 Jul 17.

¹ From the Department of APSI (D.P., C.T., J.P.), Intensive Care Unit, Geneva University Hospital; Diagnostic Department (M.-I.V.), Division of Neuroradiology, Geneva University Hospital; Medicine Department (M.S.), Division of Infectiology, Geneva University Hospital; Medicine Department (O.G.), Division of Internal Medicine, Geneva University Hospital; Department of Clinical Neurosciences (P.H.L.), Division of Neurology, Geneva University Hospital; Diagnostic Department (P.H.L.), Division of Laboratory Medicine, Geneva University Hospital; and Department of Pathology and Immunology (P.H.L.), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
² From the Department of APSI (D.P., C.T., J.P.), Intensive Care Unit, Geneva University Hospital; Diagnostic Department (M.-I.V.), Division of Neuroradiology, Geneva University Hospital; Medicine Department (M.S.), Division of Infectiology, Geneva University Hospital; Medicine Department (O.G.), Division of Internal Medicine, Geneva University Hospital; Department of Clinical Neurosciences (P.H.L.), Division of Neurology, Geneva University Hospital; Diagnostic Department (P.H.L.), Division of Laboratory Medicine, Geneva University Hospital; and Department of Pathology and Immunology (P.H.L.), Faculty of Medicine, University of Geneva, Geneva, Switzerland. [email protected].

No abstract available

MeSH terms